| Ident. | Authors (with country if any) | Title |
|---|
| 000022 (2012) |
Françoise Kraeber-Bodéré (France) ; Pierre-Yves Salaun ; Catherine Ansquer ; Delphine Drui ; Eric Mirallié ; Alain Faivre-Chauvet ; Jacques Barbet ; David M Goldenberg ; Jean-François Chatal | Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC). |
| 000023 (2012) |
Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-Bodéré | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. |
| 000043 (2011) |
Eliot P Botosoa (France) ; Mike Maillasson ; Marie Mougin-Degraef ; Patricia Remaud-Le Saëc ; Jean-François Gestin ; Yannick Jacques ; Jacques Barbet ; Alain Faivre-Chauvet | Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery. |
| 000046 (2010) |
F Illouz (France) ; J-L Sadoul ; V Rohmer | [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors]. |
| 000091 (2007) |
M Mougin-Degraef (France) ; C Bourdeau ; E Jestin ; C Saï-Maurel ; M Bourgeois ; P Remaud-Le Saëc ; P Thédrez ; J-F Gestin ; J Barbet ; A Faivre-Chauvet | Doubly radiolabeled liposomes for pretargeted radioimmunotherapy. |
| 000094 (2006) |
Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. |
| 000095 (2006) |
Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; | Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group. |
| 000097 (2006) |
Jean-Mathieu Chrétien (France) ; Françoise Zammattio ; Delphine Gauthier ; Erwan Le Grognec ; Michaël Paris ; Jean-Paul Quintard | Preparation of allyltin reagents grafted on solid support: clean and easily recyclable reagents for allylation of aldehydes. |
| 000116 (2005) |
Eric Mirallié (France) ; Catherine Saï-Maurel ; Alain Faivre-Chauvet ; Nicolas Regenet ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Philippe Thedrez | Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody. |
| 000129 (2003) |
Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. |
| 000139 (2002) |
Françoise Kraeber-Bodéré (France) ; Catherine Saï-Maurel ; Loïc Campion ; Alain Faivre-Chauvet ; Eric Mirallié ; Michel Chérel ; Stéphane Supiot ; Jacques Barbet ; Jean-François Chatal ; Philippe Thédrez | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. |
| 000160 (1999) |
F Kraeber-Bodéré (France) ; A Faivre-Chauvet ; C Saï-Maurel ; L Campion ; M Fiche ; E Gautherot ; J Le Boterff ; J Barbet ; J F Chatal ; P Thédrez | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. |
| 000185 (1997) |
J P Vuillez (France) ; D Moro ; P Y Brichon ; E Rouvier ; E Brambilla ; J Barbet ; P Peltier ; P Meyer ; R Sarrazin ; C Brambilla | Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. |
| 000198 (1996) |
A Faivre-Chauvet (France) ; R C Mease ; A Chetanneau ; M Bardiès ; C Sai-Maurel ; G E Meinken ; S C Srivastava ; J F Chatal ; J F Gestin | Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody. |
| 000208 (1996) |
A Devys (France) ; P Thedrez ; E Gautherot ; A Faivre-Chauvet ; C Saï-Maurel ; E Rouvier ; J L Auget ; J Barbet ; J F Chatal | Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. |
| 000222 (1995) |
J F Chatal (France) ; A Faivre-Chauvet ; M Bardies ; P Peltier ; E Gautherot ; J Barbet | Bifunctional antibodies for radioimmunotherapy. |
| 000229 (1994) |
S Lartigue (France) ; Y Bizais ; S B Des Varannes ; A Murat ; B Pouliquen ; J P Galmiche | Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. |
| 000237 (1993) |
P Peltier (France) ; J P Dutin ; J F Chatal ; P Fumoleau ; P Bourguet ; J C Liehn ; J P Vuillez ; J Y Hérry ; A Loboguerrero | Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay. |
| 000241 (1993) |
P Peltier (France) ; C Curtet ; J F Chatal ; J M Le Doussal ; G Daniel ; G Aillet ; A Gruaz-Guyon ; J Barbet ; M Delaage | Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. |
| 000244 (1993) |
A Faivre-Chauvet (France) ; J F Gestin ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F Chatal | Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. |
| 000245 (1993) |
J F Gestin (France) ; A Faivre-Chauvet ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F Chatal | Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method. |
| 000249 (1993) |
M A Slinkin (France) ; C Curtet ; A Faivre-Chauvet ; C Sai-Maurel ; J F Gestin ; V P Torchilin ; J F Chatal | Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. |
| 000254 (1992) |
M Bardiès (France) ; P Thedrez ; J F Gestin ; B M Marcille ; D Guerreau ; A Faivre-Chauvet ; M Mahé ; C Sai-Maurel ; J F Chatal | Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation. |
| 000259 (1992) |
P Peltier (France) ; K Wiharto ; J P Dutin ; J F Chatal ; P Bourguet ; J C Liehn ; J P Vuillez ; J Y Hérry ; A Loboguerrero | Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), France. |
| 000266 (1991) |
J P Vuillez (France) ; P Peltier ; J C Mayer ; F Dubois ; A Chetanneau ; P Fumoleau ; A Bertrand ; J F Chatal | Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients. |
| 000271 (1991) |
P De Faucal (France) ; P Peltier ; B Planchon ; B Dupas ; M D Touze ; D Baron ; T Scaible ; H J Berger ; J F Chatal | Evaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease. |
| 000279 (1990) |
A Chetanneau (France) ; R P Baum ; P A Lehur ; J C Liehn ; A C Perkins ; R Bares ; P Bourguet ; J Y Herry ; J C Saccavini ; J F Chatal | Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments. |
| 000283 (1990) |
C Curtet (France) ; J P Vuillez ; G Daniel ; G Aillet ; A Chetanneau ; J Visset ; M Kremer ; P Thédrez ; J F Chatal | Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody. |
| 000289 (1989) |
A Chetanneau (France) ; P A Lehur ; D Ripoche ; P Peltier ; J C Saccavini ; J P Vuillez ; N Tournemaine ; P Thedrez ; J F Chatal | Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. |
| 000292 (1989) |
J F Chatal (France) ; J C Saccavini ; J F Gestin ; P Thédrez ; C Curtet ; M Kremer ; D Guerreau ; D Nolibé ; P Fumoleau ; Y Guillard | Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. |
| 000293 (1989) |
P Thédrez (France) ; J C Saccavini ; D Nolibé ; J P Simoen ; D Guerreau ; J F Gestin ; M Kremer ; J F Chatal | Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma. |
| 000309 (????) |
L Morandeau (France) ; E Benoist ; A Loussouarn ; A Ouadi ; P Lesaec ; M Mougin ; A Faivre-Chauvet ; J Le Boterff ; J F Chatal ; J Barbet ; J F Gestin | Synthesis of new bivalent peptides for applications in the Affinity Enhancement System. |
